TechTarsFinancial Intelligence

Navigate

Browse & analyze

Why Nifty, Sensex & S&P moved

Stocks, crypto, gold & net worth

SIP, EMI, FD & more

Investing guides & market education

Your saved stocks

Preferences

Default currency

Number format

Account

Disclaimer: TechTars provides educational analytics and financial tools for informational purposes only. Nothing on this platform constitutes investment advice, financial advice, or trading recommendations. TechTars is not a SEBI-registered investment adviser or research analyst, and no content here is a recommendation to buy, sell, or hold any security. Always consult a qualified, SEBI-registered financial advisor before making investment decisions.

TechTars

Structured financial intelligence.
No tips. No noise. Just data.

Markets

Indian Stocks
US Stocks
Market Indices
Wealth Tracker

Tools

SIP Calculator
EMI Calculator
Net Worth
All Calculators

Company

About Us
About the Founder
Methodology
Blog & Guides

Legal

Privacy Policy
Terms of Service
Disclaimer

🔒Your data stays private

© 2026 TechTars.com·Market data delayed by ~15 minutes. Not investment advice.

Home
/
US Stocks
/
Eli Lilly and Company vs AbbVie Inc.

Eli Lilly and Company vs AbbVie Inc.

Side-by-side stock comparison - today's price, technicals, and structured verdict.

More US stock comparisons

→Apple Inc. vs Microsoft Corporation →Microsoft Corporation vs Alphabet Inc.→Alphabet Inc. vs Meta Platforms Inc.→NVIDIA Corporation vs Advanced Micro Devices →Advanced Micro Devices vs Intel Corporation →NVIDIA Corporation vs Intel Corporation

Written by Yadav Patle· Founder, TechTars · 7+ years tracking Indian & US markets

•

Last updated: 10 October 2026 at 6:06 am IST

•How we analyse stocksFounder, TechTars · 7+ years tracking Indian & US markets

Eli Lilly and Company (LLY) is up 0.83% while AbbVie Inc. (ABBV) is up 1.49% on the NYSE/NASDAQ. Today, AbbVie Inc. is outperforming on a percentage basis.

Eli Lilly and CompanyLLY

$1179.27

+0.83%

VS

AbbVie Inc.ABBV

$276.47

+1.49%

Eli Lilly and Company vs AbbVie Inc.: today's numbers

$1179.27

Price

$276.47

+0.83%

Today

+1.49%

35/100Developing

TechTars Score

55/100Moderate

Bullish

Market bias

Bullish

Bullish

Sentiment

Bullish

54 (neutral)

RSI

71 (overbought)

Sideways

Trend

Uptrend

-

MACD

-

$1133.80

Support

$260.83

$1202.70

Resistance

$276.70

Medium

Confidence

Medium

Why Eli Lilly and Company moved today

LLY rose 0.83% as Cantor Fitzgerald upgraded the stock price target citing strong demand trends.

Why AbbVie Inc. moved today

ABBV rose 1.49% after Cantor Fitzgerald raised its price target, citing improved drug performance.

Read full Eli Lilly and Company analysis Read full AbbVie Inc. analysis

This side-by-side comparison of LLY and ABBV is generated from publicly available price, volume, and news data using the methodology at /methodology/stock-analysis. It is educational context, not a recommendation to buy or sell either stock, and does not say which is a "better" investment. Prices and indicators change minute-to-minute. Consult a SEBI-registered investment adviser before acting on any of this information.